2019
DOI: 10.1016/j.drugpo.2019.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 75 publications
0
12
0
Order By: Relevance
“…(29) The role of MAT in the prescriber's and patient's behavior is an area that needs further exploration if the uptake of DAA treatment is to happen; however, enhancing access to MAT treatment should be taken into consideration. (30)(31)(32) In addition, the group least likely to be treated with DAAs over this study period and one that saw no change in their uptake of treatment was that with HCV/HIV and a SUD. This finding should come as no surprise, as all three diseases carry a substantial burden of stigmatization resulting in difficulty treating this cohort due to their transience, social isolation, and inadequate medical and substance use disorder treatment services.…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…(29) The role of MAT in the prescriber's and patient's behavior is an area that needs further exploration if the uptake of DAA treatment is to happen; however, enhancing access to MAT treatment should be taken into consideration. (30)(31)(32) In addition, the group least likely to be treated with DAAs over this study period and one that saw no change in their uptake of treatment was that with HCV/HIV and a SUD. This finding should come as no surprise, as all three diseases carry a substantial burden of stigmatization resulting in difficulty treating this cohort due to their transience, social isolation, and inadequate medical and substance use disorder treatment services.…”
Section: Discussionmentioning
confidence: 92%
“…( 29 ) The role of MAT in the prescriber’s and patient’s behavior is an area that needs further exploration if the uptake of DAA treatment is to happen; however, enhancing access to MAT treatment should be taken into consideration. ( 30‐32 )…”
Section: Discussionmentioning
confidence: 99%
“…The most common modes of infection are through exposure to small quantities of blood, such as through injection drug use, inadequate sterilization of medical equipment, or transfusion of unscreened blood and blood products [3,4]. Globally, there is a considerable burden of CHC and HIV infections among people who inject drugs, and the transmission of both infections continues [5,6]. Unlike the transmission modes described above, the majority of CHC patients in Taiwan are elderly, born in and around the 1950s, and are likely to have been infected by unsafe medical devices, especially in rural areas [3].…”
Section: Introductionmentioning
confidence: 99%
“…To reach the 2030 goals set by the WHO and UNAIDS could, for many countries, require scaling-up existing, but possibly also new evidence-based harm reduction services, within a larger comprehensive public health approach ( Day et al, 2018 ). Research shows that service models suit PWID differently ( Bruggmann & Litwin, 2013 ; Day et al, 2019 ) which is why some countries have opted to introduce evidence-based harm reduction services such as drug consumption rooms and heroin assisted treatment programmes, proven successful in reaching and retaining otherwise hard-to-reach PWID ( EMCDDA, 2012 , 2018 ). However, those few countries mostly found in Europe have implemented these programmes during often lengthy and intense discussions in both politics and society ( Cruz et al, 2007 ).…”
Section: Background and Aimsmentioning
confidence: 99%